KS

Kawaljeet Singh Makkar

Director DIN 02331913
DIN 02331913 First appointment Nov 2008
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Nov 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Kawaljeet Singh Makkar

Data last updated:

Kawaljeet Singh Makkar was a Director at Karshan Pharma Private Limited (from 2009) and Director at Elevate Exports Private Limited (from 2008).

DIN 02331913
First Appointment 01 Nov 2008
Oldest Company Age 18 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Karshan Pharma Private Limited U51909DL2009PTC187260
Director04 Feb 20092009Strike Off
Elevate Exports Private Limited U51909DL2008PTC181969
Director01 Nov 20082008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Karshan Pharma Private Limited
Elevate Exports Private Limited
Premium access

Shareholding and investment profile for Kawaljeet Singh Makkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kawaljeet Singh Makkar

Kawaljeet Singh Makkar was first appointed on 01 Nov 2008 as Director at Elevate Exports Private Limited. The most recent appointment on record is 04 Feb 2009 at Karshan Pharma Private Limited.

Kawaljeet Singh Makkar held 2 earlier board appointments: Karshan Pharma Private Limited (Director, from 04 Feb 2009); Elevate Exports Private Limited (Director, from 01 Nov 2008).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available